U.S., Oct. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07220551) titled 'A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants' on Oct. 22.
Brief Summary: The purpose of this study is to estimate the relative bioavailability of UCB0022 Formulation 2 (Test) versus Formulation 1 (Reference) in healthy participants following single oral administration.
Study Start Date: Oct. 22
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: UCB0022
Participants will receive a single oral dose of UCB0022 tablet Formulation 1 and UCB0022 tablet Formulation 2 following a pre-specified sequence.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: UCB Biopharma SRL...